Thorax perfusion CT in non-small cell lung cancer

被引：19
|
作者：
Ovali, Gulgun Yilmaz
Sakar, Aysin
Goektan, Cihan
Celik, Pinar
Yorgancioglu, Arzu
Nese, Nalan
Pabuscu, Yueksel
机构：
[1] Celal Bayar Univ, Dept Radiol, Manisa, Turkey
[2] Celal Bayar Univ, Dept Pulmonol, Manisa, Turkey
[3] Celal Bayar Univ, Dept Pathol, Manisa, Turkey
来源：
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS | 2007年 / 31卷 / 08期
关键词：
perfusion; non-small cell lung tumor; computed tomography; thorax;
D O I：
10.1016/j.compmedimag.2007.08.005
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
Objectives: We aimed to determine the perfusion differences according to the histological type, stage, volume and prognoses in the non-small cell carcinoma by thorax perfusion CT. Materials and methods: Twenty-four non-small cell carcinoma patients were included in the study. Thorax perfusion CT was done to evaluate the tumors in terms of perfusion parameters: blood flow (BF) and time to peak (TTP) values. Results: The total blood flow of the tumor in squarnous cell carcinoma was significantly higher than adenocarcinoma (P = 0.03 1). There was no statistical difference between the perfusion parameters and other parameters. Conclusions: Perfusion CT may help us in evaluating non-small cell carcinomas. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：686 / 691
页数：6
相关论文
共 50 条
  • [41] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [42] The lymphadenectomy in non-small cell lung cancer
    Chiappetta, Marco
    VIDEO-ASSISTED THORACIC SURGERY, 2022, 7
  • [43] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [44] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [45] Pneumonectomy for non-small cell lung cancer
    Ichiki, Yoshinobu
    Nagashima, Akira
    Chikaishi, Yasuhiro
    Yasuda, Manabu
    SURGERY TODAY, 2012, 42 (09) : 830 - 834
  • [46] METASTASE IN NON-SMALL CELL LUNG CANCER
    Luan Van Pham
    Tien Dinh Nguyen
    Hai Minh Nguyen
    Tien Dao Nguyen
    Duyen Thi Thi
    Son Van Nguyen
    Dai Van Tran
    RESPIROLOGY, 2019, 24 : 272 - 272
  • [47] Docetaxel and non-small cell lung cancer
    Le Guen, Y
    Le Cesne, A
    BULLETIN DU CANCER, 2004, 91 (03) : 263 - 270
  • [48] Value of lung perfusion in stage III non-small cell lung cancer patients treated with radiotherapy
    Li, B.
    Wang, Z.
    Yin, Y. O. N. G.
    Yang, G.
    Fu, Z.
    Hu, X.
    Yan, J. I. N. G.
    Zhou, T. A. O.
    EJC SUPPLEMENTS, 2007, 5 (04): : 382 - 382
  • [49] Sorafenib in non-small cell lung cancer
    Zhang, Jianjun
    Gold, Kathryn A.
    Kim, Edward
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) : 1417 - 1426
  • [50] Bevacizumab in non-small cell lung cancer
    Di Costanzo, Francesco
    Mazzoni, Francesca
    Mela, Marinella Micol
    Antonuzzo, Lorenzo
    Checcacci, Daniele
    Saggese, Matilde
    Di Costanzo, Federica
    DRUGS, 2008, 68 (06) : 737 - 746
12345